Target intelligence / Profile preview

Late Cornified Envelope Pseudogene 4 (LCEP4)

Target
LCEP4
Molecular classification
Pseudogene, Noncoding RNA gene (potential source of long noncoding RNAs/lncRNAs)
01

Overview

LCEP4 (Late Cornified Envelope Pseudogene 4) is an annotated pseudogene in the human epidermal differentiation complex (EDC) on chromosome 1q21. It is structurally related to the small proline-rich protein family and late envelope proteins (LEPs), which are incorporated late during the maturation of the epidermal cornified envelope to support barrier function in differentiated keratinocytes. Unlike functional late envelope protein genes, LCEP4 is considered a pseudogene and does not encode a known functional protein. Although some pseudogenes are now recognized for their regulatory potential—for example, through the generation of long noncoding RNAs (lncRNAs) that modulate the expression of other genes—the specific biological role and regulatory impact of LCEP4 have not been demonstrated. LCEP4 is not considered a therapeutic target, biomarker, or molecule implicated in disease causation, and no drugs or mechanisms of action are known to interact with it. Summary of key points: - LCEP4 is a pseudogene, not a protein-coding gene, and not a receptor, enzyme, transporter, or drug target. - Its function, if any, is likely limited to potential noncoding RNA regulatory activities typical of pseudogenes, but this is unconfirmed in the case of LCEP4. - No disease association, drug interactions, or biomarker use for LCEP4 have been reported. - LCEP4 is not a canonical or actionable target in biomedical research or therapy.

Other names
Small proline rich-like (epidermal differentiation complex) 1B pseudogeneLCEP4
02

Biological functions

Possible regulation of gene expression via noncoding RNA mechanisms typical of pseudogenes, but no experimentally validated biological function for LCEP4
03

Disease associations

General roles in lncRNA-mediated regulation and genomic evolution have been described for pseudogenes, but no disease association or pathological role specifically attributed to LCEP4

Beyond the preview

Go deeper on Late Cornified Envelope Pseudogene 4 (LCEP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Late Cornified Envelope Pseudogene 4 (LCEP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call